Evidence map›Paper›PMID 39045970›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2024

Efficacy of probiotics, paraprobiotics, and postbiotics in colorectal cancer cell line and their role in immune response.

Gülçin Alp Avci, Ülkü İrem Yilmaz, Emre Avci

Abstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Anticancer Potential ofInternational journal of molecular sciences · 2026
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Evaluation ofFood science & nutrition · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gülçin Alp AvciUniversity of Health Sciences, Faculty of Gulhane Dentistry, Department of Basic Medical Sciences - Ankara, Turkey.ORCID http://orcid.org/0000-0003-4049-0756
Ülkü İrem YilmazUniversity of Health Sciences, Gülhane Vocational School of Health, Department of Pathology - Ankara, Turkey.ORCID http://orcid.org/0000-0002-9531-0479
Emre AvciUniversity of Health Sciences, Faculty of Gulhane Pharmacy, Department of Biochemistry - Ankara, Turkey.ORCID http://orcid.org/0000-0003-1046-8208

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to reveal certain features (anti-tumor/microbial activities) of postbiotics and heat-inactivated paraprobiotics obtained from two different bacteria with determined probiotic properties, which are thought to contribute to human health.

methodsIn the study, Lactobacillus reuteri ENA31 and L. rhamnosus GAA6 strains were used. Supernatants of postbiotically active cultures were used. Paraprobiotics were obtained by exposing probiotic bacteria to high temperatures. The cytotoxic effects of probiotics, paraprobiotics, and postbiotics were evaluated by the MTT method. IL-1/-10/-12/-13, TNF-α, IFN-γ, and neopterin parameters were determined via the ELISA method in immunity studies.

resultsIt was detected that biotics had a cytotoxic effect on cancer cells with rising concentrations (paraprobiotic<probiotic<postbiotics, respectively). Intercalarily, with these biotic applications, a decline in the values of IL-1, IFN-γ, TNF-α, and neopterin and a rise in the values of IL-10/-12/-13 were observed in cancer cells.

conclusionOur study shows that biotics, which are widely used and beneficial to health, are also available for use in immunocompromised individuals. The resulting paraprobiotics and postbiotics will both increase the conscious use of probiotics and provide the opportunity for use in immunocompromised individuals.

Indexed as

Colorectal NeoplasmsLacticaseibacillus rhamnosusProbioticsCell Line, TumorCytokinesEnzyme-Linked Immunosorbent AssayHumansLimosilactobacillus reuteriNeopterinCytokinesNeopterin

Identifiers

PMID39045970
PMCPMC11288267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.